Menu

ImmuCell Corporation ICCC

Full chart Compare
Set alert

Price alert · ICCC

All alert types
9.95 USD -0.42 (-4.05%)

At closeNov 5, 2026, 4:00 PM EST

9.90 -0.05 -0.49%

After hours · Nov 5, 4:00 PM ET

9.60 Day range 10.40
4.56 52-week range 11.72
YTD
+61.79%
1 year
+57.94%

Revenue & Expenses

Revenue → Gross Profit: $11.45MGross Profit → Expenses: $11.45MRevenue → Cost of Revenue: $16.20MExpenses → Selling, General & Admin: $6.75MExpenses → Research & Development: $3.04MExpenses → Interest Expense: $439.04KExpenses → Other Expenses: $2.24MExpenses → Income Tax: $11.57KNet Loss → Expenses: $1.04MGross Profit$11.45MNet Loss$1.04MCost of Revenue$16.20MExpenses$12.49MSelling, General & Admin$6.75MResearch & Development$3.04MInterest Expense$439.04KOther Expenses$2.24MIncome Tax$11.57KRevenue$27.64M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ICCC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
27.64M26.49M17.47M18.57M19.24M
11.45M7.94M3.87M7.65M8.66M
1.65M-1.64M-5.75M-2.30M257.38K
-1.04M-2.16M-5.77M-2.49M-78.29K
-0.12-0.26-0.75-0.32-0.01
ICCC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.81M3.76M978.74K5.79M10.19M
42.53M45.10M43.81M44.86M44.47M
15.48M17.58M18.82M14.48M11.89M
13.19M15.10M16.69M12.48M10.27M
27.06M27.52M24.99M30.38M32.58M
ICCC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.48M357.90K-4.67M-1.54M954.17K
-1.21M-461.23K-1.89M-3.96M-1.60M
-1.21M2.88M1.75M1.11M3.88M
-1.21M-461.23K-1.89M-3.96M-2.59M
48.60K2.78M-4.81M-4.39M3.24M